C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors

L Barroilhet; J Yang; K Hasselblatt; R M Paranal; S-K Ng; J A Rauh-Hain; W R Welch; J E Bradner; R S Berkowitz; S-W Ng

doi:10.1038/onc.2012.380

C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors

Oncogene ◽

10.1038/onc.2012.380 ◽

2012 ◽

Vol 32 (33) ◽

pp. 3896-3903 ◽

Cited By ~ 23

Author(s):

L Barroilhet ◽

J Yang ◽

K Hasselblatt ◽

R M Paranal ◽

S-K Ng ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Binding Protein ◽

Ovarian Cancer Cells

Download Full-text

Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-04-0107 ◽

2005 ◽

Vol 4 (4) ◽

pp. 603-611 ◽

Cited By ~ 40

Author(s):

Kevin A. Strait ◽

C. Terry Warnick ◽

Clyde D. Ford ◽

Bashar Dabbas ◽

Elizabeth H. Hammond ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Ovarian Cancer Cells ◽

Related Protein ◽

G2 Checkpoint

Download Full-text

Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis

Current Medicinal Chemistry ◽

10.2174/092986707782023299 ◽

2007 ◽

Vol 14 (24) ◽

pp. 2548-2553 ◽

Cited By ~ 32

Author(s):

Noriyuki Takai ◽

Hisashi Narahara ◽

Noriyuki Takai ◽

Hisashi Narahara

Keyword(s):

Cell Cycle ◽

Ovarian Cancer ◽

Cell Cycle Arrest ◽

Cancer Cells ◽

Histone Deacetylase ◽

Antiproliferative Activity ◽

Histone Deacetylase Inhibitors ◽

Ovarian Cancer Cells ◽

Induce Cell Cycle Arrest ◽

Cycle Arrest

Download Full-text

Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin

Oncology Letters ◽

10.3892/ol.2017.6978 ◽

2017 ◽

Cited By ~ 2

Author(s):

Jinli Zhang ◽

Xifeng Xiong ◽

Xing Hua ◽

Wenjuan Cao ◽

Shengnan Qin ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Cancer Cells ◽

Binding Protein ◽

Ovarian Cancer Cells

Download Full-text

Histone deacetylase 4 increases progressive epithelial ovarian cancer cells via repression of p21 on fibrillar collagen matrices

Oncology Reports ◽

10.3892/or.2015.4423 ◽

2015 ◽

Vol 35 (2) ◽

pp. 948-954 ◽

Cited By ~ 5

Author(s):

YU-FEI SHEN ◽

AI-MIN WEI ◽

QING KOU ◽

QIAO-YING ZHU ◽

LEI ZHANG

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Ovarian Cancer Cells ◽

Fibrillar Collagen ◽

Collagen Matrices ◽

Histone Deacetylase 4

Download Full-text

Abstract 2985: DNA-damage related histone marks can distinguish the anti-tumor effects of established and novel histone deacetylase inhibitors in ovarian cancer cells

10.1158/1538-7445.am10-2985 ◽

2010 ◽

Author(s):

Andrew J. Wilson ◽

Ed Holson ◽

Srividya Bhaskara ◽

Jahred Carlise ◽

Stuart L. Schreiber ◽

...

Keyword(s):

Ovarian Cancer ◽

Dna Damage ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Ovarian Cancer Cells ◽

Histone Marks

Download Full-text

Expression of FK506 binding protein 65 (FKBP65) is decreased in epithelial ovarian cancer cells compared to benign tumor cells and to ovarian epithelium

Tumor Biology ◽

10.1007/s13277-011-0167-4 ◽

2011 ◽

Vol 32 (4) ◽

pp. 671-676 ◽

Cited By ~ 5

Author(s):

Rudi Henriksen ◽

Flemming Brandt Sørensen ◽

Torben Falck Ørntoft ◽

Karin Birkenkamp-Demtroder

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Cancer Cells ◽

Tumor Cells ◽

Benign Tumor ◽

Binding Protein ◽

Ovarian Cancer Cells ◽

Fk506 Binding Protein

Download Full-text

C-terminal binding protein 2: A potential marker for response to histone deacetylase inhibitors in epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.12.152 ◽

2011 ◽

Vol 120 ◽

pp. S63

Author(s):

L. Barroilhet ◽

J. Yang ◽

K. Hasselblatt ◽

J. Rauh-Hain ◽

W. Welch ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Binding Protein ◽

Potential Marker

Download Full-text

Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells

Oncology Reports ◽

10.3892/or.20.1.219 ◽

2008 ◽

Cited By ~ 1

Author(s):

Jürgen Sonnemann ◽

Isabel Hüls ◽

Michael Sigler ◽

Chithra Palani ◽

Le Hong ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Death ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Ovarian Cancer Cells ◽

Induce Cell Death

Download Full-text

Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-007-0423-4 ◽

2007 ◽

Vol 277 (1) ◽

pp. 15-19 ◽

Cited By ~ 6

Author(s):

Kun Zhu ◽

Danni Qu ◽

Takanori Sakamoto ◽

Ichio Fukasawa ◽

Masatoshi Hayashi ◽

...

Keyword(s):

Ovarian Cancer ◽

Cell Proliferation ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitors ◽

Ovarian Cancer Cells

Download Full-text

ROS production is required for follicle-stimulating hormone-induced Nrf2 activation in human epithelial ovarian cancer cells

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2012.00935 ◽

2013 ◽

Vol 32 (9) ◽

pp. 935-939

Author(s):

Jie MA ◽

Qian-qian WANG ◽

Hong LIAO ◽

Yong-bin YANG ◽

Zhi-jun JIN ◽

...

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Cancer Cells ◽

Follicle Stimulating Hormone ◽

Ovarian Cancer Cells ◽

Ros Production ◽

Nrf2 Activation ◽

Stimulating Hormone

Download Full-text